Senseonics logo
Senseonics
SENS | NASDAQ
Chart Builder DCF Calculator
$10.90
+$0.32 (+3.02%)
At close: Nov 16, 2026, 4:00 PM ET
$11.05
+$0.15 (+1.38%)
After-hours: Nov 16, 2026, 7:54 PM ET

Senseonics Company Profile

Company profile explained

Company Profile

Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems. These innovative solutions cater to individuals with diabetes across the United States, Europe, the Middle East, and Africa. The company's core product offerings, Eversense and Eversense XL, are advanced implantable CGM devices. They function by continuously tracking glucose levels through an under-the-skin sensor, a detachable and rechargeable smart transmitter, and an intuitive mobile application. This setup enables real-time diabetes monitoring and management for durations of up to half a year. Senseonics delivers its products and services to healthcare providers and patients alike via an extensive network of distributors and strategic fulfillment partners. Additionally, the firm maintains a collaborative agreement with the University Hospitals Accountable Care Organization. Founded in 1996, Senseonics Holdings, Inc. is headquartered in Germantown, Maryland.

Key Executives

Name Position
Timothy T. Goodnow President, Chief Executive Officer & Director
Frederick T. Sullivan Chief Financial Officer, Secretary & Treasurer
Mukul Jain Chief Operating Officer
Brian Hansen Chief Commercial Officer & Director
Francine Ratner Kaufman Chief Medical Officer & Director
Kenneth L. Horton General Counsel & Corporate Development Advisor

Latest SEC Filings

Date Type Title
Oct 27, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Oct 05, 2026 4 Filing
Oct 05, 2026 4 Filing
Oct 05, 2026 4 Filing
Oct 05, 2026 4 Filing
Aug 20, 2026 4 Filing
Aug 14, 2026 SC 13G Statement of acquisition of beneficial ownership b...
Aug 06, 2026 10-Q Quarterly Report
Aug 06, 2026 8-K Current Report
Jul 30, 2026 SC 13G Statement of acquisition of beneficial ownership b...
View All SEC Filings ➞
Senseonics
Senseonics logo
Country United States
IPO Date Dec 22, 2015
Industry Medical - Devices
Sector Healthcare
Employees 130
CEO Timothy T. Goodnow

Contact Details

20451 Seneca Meadows Parkway Germantown, Maryland 20876-7005 United States

Stock Details

Ticker Symbol SENS
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001616543
CUSIP Number 81727U303
ISIN Number US81727U3032
SIC Code 3823

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.